Open Nav
2019 Participating Investors

Below is a representative list of participating investment firms and sell side research analysts for the 2019 BIO Investor Forum:

3E Bioventures
Abingworth Management
Agent Capital
Aleph Capital
Alignment Ventures
Altitude Life Science Ventures
Andreessen Horowitz
Arch Venture Partners
ARTIS Ventures
Asahi Kasei America
Asset Management Ventures
Astellas Innovation Management 
Astellas Pharma US
Barbara Lavery
Biomark Capital
BioPacific Investors
Bios Partners
Borex Capital
Boryung Holdings
Brace Pharma Capital
Brain Trust Accelerator Fund
Capital Family Office
CEC Capital
Chaperone Investment
China Grand
Cowin Capital
Crosswave Management
Danaher Life Sciences
Data Collective Venture Capital
DAYLI Partners
Defta Partners
Dolby Family Ventures
Dorset Capital
Emerson Collective
FMG Ventures
F-Prime Capital Partners
GE Ventures
Genoa Ventures
Global Neurohealth Ventures
GreenSky Capital
Hannol Ventures
Hbm Partners
HEDA Ventures
Hemi Ventures
Iaso Ventures
Illumina Accelerator

Illumina Ventures
Johnson & Johnson Development Corporation
Joyance Partners
Julz Co
Juvenile Diabetes Research Foundation (JDRF)
KB Financial Group
Laurel Venture Capital
Life Science Angels
Lumira Ventures
Lyfe Capital
LYZZ Capital Advisors
Matthews Asia
Matthews International Capital Management
Milestone Capital
Mitsui & Co. Global Investment
Momentum Biotech
New Enterprise Associates (NEA)
Nomura Instinet
Northern Light Venture Capital
Novo Ventures (US)
Oresund Capital
OSF Healthcare Ventures
Otsuka Pharmaceutical Co.
Palo Alto Investors
Panacea Venture Healthcare
PoC Capital
Premier Partners
Prevail Partners
Quan Capital
RBV Capital
Remiges Ventures
Research Bridge Partners
Roche Venture Fund
Satter Medical Technology Partnership
Taiho Ventures
The Leukemia & Lymphoma Society
Tosoh USA
VantagePoint Capital Partners
venBio Partners
Vertex Venture Holdings
Vivo Capital
Voya Financial
WI Harper Group
Xeraya Capital Life Venture
Yonjin Capital
Yuhan USA
ZJ Future

*As of  8/17/2019